CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- 4 Open-market buy Exec. VC - Strategic Dev. bought 1,000,000 shares at $1.61 ($1,610,000)
- 4 Open-market buy Director bought 25,000 shares at $1.61 ($40,250)
- 4 Open-market buy President and CEO bought 150,000 shares at $1.61 ($241,500)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $1.37 ($6,850)
- 4 Open-market sale Former Chief Medical Officer sold 47,566 shares at $1.89 ($89,976)
- 4 Open-market sale Former Chief Medical Officer sold 19,000 shares at $1.81 ($34,382)
- 4 Open-market sale Former Chief Medical Officer sold 101 shares at $1.85 ($187)
- 4/A Open-market buy President and CEO bought 2,000 shares at $6.95 ($13,900)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Exec. VC - Strategic Dev. acquired 3,958,692 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy Chief Financial Officer bought 4,545 shares at $7.90 ($35,906)
- 4 Open-market buy Chief Financial Officer bought 1,107 shares at $1.39 ($1,539)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 1,979,346 shares (grant or award)
Page 11 of 15 · 291 filings